As per Christine's
message of yesterday, here is the press release as it went out over the
wires. To this I will add that I hear that a trial for AMN107 will
probably start in a couple of months at Hopital Maisonneuve Rosemont in Montreal
which is part of the CHUM (Centre Hospitalier universite de Montreal) or as we
affectionately refer to here in Montreal as the "French"
hospitals.
So, it is really
good to hear that Montreal will have access to important clinical
trials.
Researchers to test new leukemia drug |
| Posted By: News-Medical in Medical Research
News |
| Published: Wednesday, 12-Jan-2005 |
|
| |
|
Chronic myeloid leukemia (CML) is a
malignant cancer of the blood that affects people of all ages. While
treatment is available for most of these patients, approximately 20
percent of them do not respond to it. Researchers at McGill teaching hospitals will soon
study the effects of a new alternative therapy.
"Gleevec(TM) has become the standard treatment for CML," says Dr.
Carlo Gambacorti-Passerini, Canada Research Chair in Oncology at
McGill University. "It is remarkably effective for most patients;
however, some become resistant to it. We will be looking at a new
drug called BMS-354825. Initial analyses of this compound are
positive and the side effects are minimal, especially when compared
to those of chemotherapy."
The new research is planned to start in January at McGill
University teaching hospitals, the only institutes in Canada where
this treatment will be available. The hospitals that will test
BMS-354825 include the Sir Mortimer B. Davis – Jewish General
Hospital, the McGill University Health Centre and St. Mary's
Hospital. Five different treatment scenarios will be tested. Three
of these will include patients with chronic or accelerated-phase
CML, and will be supervised by Dr. Gambacorti-Passerini at the
Jewish General Hospital. The two other scenarios will include
patients with acute forms of leukemia and will be directed by Dr.
Pierre Laneuville, Director of Hematology at the McGill University
Health Centre.
"Running these innovative clinical studies is an invaluable
opportunity for both the University and our patients — who may
benefit from participation and access to this treatment," stated Dr.
Gerald Batist, Chairman of Oncology at McGill.
http://www.mcgill.ca | |
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com
Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com
CML (Chronic Myelogenous Leukemia Support List)
---------------------------------
Part Of CMLHope.Com
An International Community Of CML Patients
For more information: http://cmlhope.com
Post Message: [email protected]
Subscribe: [EMAIL PROTECTED]
Unsubscribe: [EMAIL PROTECTED]
Change To No Mail/Web: [EMAIL PROTECTED]
Change To Digest: [EMAIL PROTECTED]
Change To Email: [EMAIL PROTECTED]
List Help: [EMAIL PROTECTED]
CML Group Web Site http://groups.yahoo.com/group/CML
Yahoo! Groups Links
